Glycine sermorelin acetate explained: what the peptide is, how glycine fits in, how it compares with other sermorelin forms, and what US users should know.
There is no distinct drug called "glycine sermorelin acetate." Sermorelin acetate is a synthetic 29-amino-acid peptide that mirrors the first 29 amino acids of human growth hormone-releasing hormone (GHRH), and glycine is already built into that chain as the 15th residue. Glycine is a component of sermorelin, not a competing version of it.
That one fact clears up most of the confusion behind the search. People run into the phrase "glycine sermorelin acetate" in two different places: on peptide sequence charts, where glycine sits inside the molecule, and on product labels, where glycine can appear as an inactive ingredient in the vial or the diluent. If you are trying to work out what is sermorelin acetate, start with the sequence and the salt form, and the rest follows from there.
Glycine Is Part of the Sermorelin Molecule
Sermorelin's chain starts with tyrosine and ends with arginine amide, and glycine occupies position 15. Every sermorelin peptide contains that glycine residue, including the acetate form sold by compounding pharmacies and research suppliers.
A related compound is where the confusion usually starts. Modified GRF(1-29), frequently sold as CJC-1295 without DAC, replaces glycine at position 15 with alanine so the peptide resists enzymatic breakdown. When people compare sermorelin glycine vs sermorelin acetate, they are usually weighing a native glycine-containing sequence against a salt-form label, or the native sequence against the alanine-modified analog.
What "Acetate" Adds to the Molecule
The sermorelin acetate peptide is the same 29-amino-acid chain paired with an acetate counter-ion. Acetate is a common pharmaceutical salt that improves stability and solubility during manufacturing and freeze-drying.
The difference people usually mean when they compare sermorelin acetate vs sermorelin is salt form versus free base. Both terms describe the same parent peptide. In practice, the acetate version is what shows up in most vials and research catalogs, typically as a lyophilized powder that must be reconstituted before use.
How the Related Terms Compare
| Name | What it actually is | Glycine content |
|---|---|---|
| Sermorelin | Native 29-amino-acid GHRH analog (GRF 1-29) | Glycine at position 15 |
| Sermorelin acetate | The same peptide bound to an acetate counter-ion | Glycine at position 15 |
| Mod GRF(1-29) / CJC-1295 no DAC | Stabilized analog with several substitutions | Glycine swapped for alanine at position 15 |
| Glycine (standalone) | An amino acid supplement, often sold for sleep | It is glycine |
| GHRP-2 and GHRP-6 | Ghrelin-receptor agonists, a different drug class | Unrelated to sermorelin's sequence |
Glycine Also Appears as an Excipient
Some lyophilized peptide products list glycine as an inactive ingredient. In that role, glycine acts as a bulking agent and cryoprotectant: it helps the powder form an even cake and protects the peptide during freeze-drying.
Glycine is also sold on its own as an oral supplement, usually in 1 to 3 gram doses, and marketed mainly for sleep quality. A glycine capsule and a vial of sermorelin acetate are not interchangeable. Taking oral glycine will not produce the pituitary signaling that sermorelin does.
What Sermorelin Acetate Is Claimed to Do
Sermorelin binds GHRH receptors in the pituitary and prompts the body to release its own growth hormone. Because that release is pulsatile and self-limited, it is often described as gentler than injecting growth hormone directly.
Marketing around sermorelin-acetate for weight loss is common, and some clinics also promote it for body composition, sleep, and recovery. The honest summary is narrower: older studies in children with growth hormone deficiency showed it could raise growth hormone and IGF-1, but there is little high-quality modern evidence for weight loss or anti-aging benefits in healthy adults.
How It Compares With Other GH-Related Peptides
Bodybuilding forums often lump ghrp 2/ ghrp 6/ sermorelin acetate into a single category of "GH peptides," even though they work through different receptors. GHRP-2 and GHRP-6 act on the ghrelin receptor, while sermorelin acts on the GHRH receptor. Combining them is a research question, not a proven protocol, and stacking increases both the chance of side effects and the difficulty of reading lab results.
Legal Status and Safety in the United States
Sermorelin acetate is not FDA-approved for human use in the United States today. The original brand product, Geref, was approved in 1990 for evaluating and treating growth hormone deficiency in children, but it was discontinued in 2008.
Since then, sermorelin has largely moved into two channels: compounding pharmacies that prepare it under a prescription, and research-chemical vendors that sell it labeled "not for human consumption." Quality, sterility, and actual peptide content vary widely between sources, and regulators have raised concerns about the compounded versions as well.
Reported side effects include injection-site reactions, flushing, headache, dizziness, and shifts in blood sugar or IGF-1 levels. Anyone considering it should speak with a licensed healthcare professional, get baseline labs, and avoid self-dosing from an unverified vial. Instructions copied from a forum are not a substitute for guidance from a clinician.
Practical Takeaways
- Glycine is the 15th amino acid in sermorelin, so it is part of the molecule rather than a separate product option.
- Sermorelin acetate and sermorelin refer to the same peptide; acetate simply names the salt form.
- Modified GRF(1-29) is the analog that replaces glycine with alanine, and it should not be confused with sermorelin.
- Sermorelin acetate is not FDA-approved for human use in the United States.
- Claims about weight loss, anti-aging, or recovery are not supported by strong modern clinical evidence in healthy adults.
Frequently Asked Questions
Is glycine sermorelin acetate a real peptide?
Not as a distinct product. Sermorelin acetate is the 29-amino-acid GHRH analog paired with an acetate counter-ion, and glycine is the amino acid at position 15 within that sequence. Some products also list glycine separately as an inactive excipient used during freeze-drying.
Is sermorelin acetate FDA-approved for human use?
Not currently. Geref, the original sermorelin acetate brand, was FDA-approved in 1990 for growth hormone deficiency in children but was discontinued in 2008. Today it is sold mainly through compounding pharmacies under a prescription or as a research chemical labeled not for human consumption.
What is the difference between sermorelin glycine and sermorelin acetate?
Sermorelin glycine generally refers to the native peptide sequence, which contains glycine at position 15. Sermorelin acetate is that same peptide bound to an acetate salt, so the two terms describe one molecule from different angles rather than two separate drugs.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.